3 recruiting, 1 not yet recruiting. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Recruiting 3, Not yet recruiting 1 |
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow AK138D1: new trials by email Literature Review of AK138D1 trials Research Report on AK138D1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Non-Small Cell Lung Cancer AK138D1, Ivonescimab, Carboplatin - Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | Recruiting | Akeso | 265 | 2026-07-07 | 2026-07-29 |
| A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer AK138D1, Ivonescimab, treatment of physician's choice - Breast Cancer | Phase 1 / Phase 2 | Not yet recruiting | Akeso | 286 | 2026-06-06 | 2026-04-30 |
| A Study of AK138D1 in Advanced Malignant Tumors AK138D1 - Solid Cancer | Phase 1 | Recruiting | Akeso | 200 | 2025-10-22 | 2025-12-15 |
| A Phase I Study of AK138D1 in the Treatment of Advanced Solid Tumors AK138D1 - Solid Cancer | Phase 1 | Recruiting | Akeso | 100 | 2025-02-24 | 2025-03-06 |
Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1)
Akeso (4)
China (3) · Australia (1)
Fei Ma (1) · Ting Luo (1) · Tong Liu (1) · Wenting Li, MD (1)